A deep neural network can be used to classify coronary artery disease from clinical heart disease features, according to new work published in the International Journal of Dynamical Systems and Differential Equations.
Jun 30, 2022
0
2
Researchers have developed a world-first blood test which improves the prediction of the long-term risk of heart attack or death in those with severe coronary artery disease.
Jun 14, 2018
0
17
A groundbreaking study published today in AACC's Journal of Applied Laboratory Medicine shows that a new test could improve diagnosis and treatment of heart disease by measuring how effectively a patient's high-density lipoprotein ...
Jun 6, 2017
0
10
Three new genetic variants that regulate gene expression in the arteries are connected to fibromuscular dysplasia, an arterial disease that can cause dangerous consequences for the heart and vessels, according to a new study.
Oct 15, 2021
0
61
Patients with psoriasis treated with biologic therapy, which are protein-based infusions to suppress inflammation, had a significant reduction in high-risk plaque in heart arteries, over one-year, according to new research ...
Sep 15, 2020
1
117
A machine learning model can effectively predict a patient's risk for a sleep disorder using demographic and lifestyle data, physical exam results and laboratory values, according to a new study published this week in the ...
Apr 12, 2023
0
71
Increased levels of lipoprotein(a), a variant of "bad cholesterol" in the bloodstream, are a risk factor for recurrent coronary heart disease (CHD) in people aged 60 or over, according to the results of a new study which ...
Jun 13, 2023
0
9
he primary results of the Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 trial found that percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) did not meet noninferiority ...
Nov 8, 2021
0
2
Mayo Clinic researchers studied the outcomes of 483 high-risk patients treated for COVID-19 with a five-day oral regimen of nirmatrelvir and ritonavir, together marketed as Paxlovid. Only a handful developed COVID-19 rebound ...
Jun 14, 2022
0
8
Even though most medical practitioners may opt not to perform procedures on higher-risk patients, new research finds that it may be a good idea for those who suffer from both atrial fibrillation and heart disease.
Mar 17, 2019
0
20
